Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA.
Saved in:
| Title: | Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA. |
|---|---|
| Authors: | Hunter T; Eli Lilly and Company, Indianapolis, IN, USA. hunter_theresa_marie@lilly.com., Grabner M; HealthCore, Inc., Wilmington, DE, USA., Birt J; Eli Lilly and Company, Indianapolis, IN, USA., Isenberg K; Anthem, Inc., Indianapolis, IN, USA., Shan M; Eli Lilly and Company, Indianapolis, IN, USA., Teng CC; HealthCore, Inc., Wilmington, DE, USA., Wu J; Eli Lilly and Company, Indianapolis, IN, USA., Griffing K; Eli Lilly and Company, Indianapolis, IN, USA., Lisse J; Eli Lilly and Company, Indianapolis, IN, USA., Curtis JR; University of Alabama at Birmingham, Birmingham, AL, USA. |
| Source: | Clinical rheumatology [Clin Rheumatol] 2022 Sep; Vol. 41 (9), pp. 2863-2874. Date of Electronic Publication: 2022 Jun 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1434-9949 |
|---|---|
| DOI: | 10.1007/s10067-022-06230-y |
